Sertraline and Cognitive Therapy for Depression and Alcohol Reduction

The study focuses on individuals battling both depression and alcoholism. It aims to find out if a combination of a medication called sertraline (Zoloft) and cognitive behavior therapy can help improve depression symptoms and reduce alcohol consumption. This research is important as it could potentially offer a more effective treatment approach for those dealing with these co-occurring conditions, ultimately improving their quality of life. In this 12-week study, participants are randomly assigned to one of two groups. One group receives sertraline (Zoloft) and cognitive behavior therapy, while the other group receives a placebo (a pill with no active ingredients) and the same therapy. Neither the participants nor the researchers know who is receiving the medication or the placebo. The study is double-blind, meaning it ensures unbiased results. After the treatment period, there are follow-up assessments at 1 and 3 months to evaluate the effectiveness of the treatment. The study measures the participants' progress based on improvements in depression symptoms and reduction in alcohol consumption.